Jane Street Group, LLC Bria Cell Therapeutics Corp. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.0 - $8.31 $140,424 - $388,974
46,808 Added 93.09%
97,092 $546,000
Q2 2022

Aug 16, 2022
BUY
$4.28 - $11.9 $64,422 - $179,118
15,052 Added 42.72%
50,284 $290,000
Q3 2021

Nov 16, 2021
BUY
$4.4 - $9.28 $155,020 - $326,952
35,232 New
35,232 $285,000

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $11.3M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email